These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22795598)

  • 41. Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants.
    Holguín A; Gutiérrez M; Portocarrero N; Rivas P; Baquero M
    J Clin Virol; 2009 Jun; 45(2):150-2. PubMed ID: 19451023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A comparative study of technics for the diagnosis of the human immunodeficiency virus in infants under 15 months by: viral cultivation, the polymerase chain reaction and antigen p24].
    Muñoz Fernández MA; Obregón González E; Navarro Caspistegui J; Gurbindo Gutiérrez MD; Hernández Sampelayo T; Fernández-Cruz E
    An Esp Pediatr; 1996 Jun; 44(6):540-4. PubMed ID: 8849094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window.
    Speers D; Phillips P; Dyer J
    J Clin Microbiol; 2005 Oct; 43(10):5397-9. PubMed ID: 16208030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a new third-generation ELISA for the detection of HIV infection.
    Yeom JS; Lee JB; Ryu SH; Kang HJ; Kim S; Kim YA; Ahn SY; Cha JE; Park JW
    Ann Clin Lab Sci; 2006; 36(1):73-8. PubMed ID: 16501240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24.
    Fitzgerald N; Cross M; O'Shea S; Fox J
    Sex Transm Infect; 2017 Mar; 93(2):100-101. PubMed ID: 27272704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with algorithm-defined acute HIV-1 infection specimens.
    Parker MM; Bennett SB; Sullivan TJ; Fordan S; Wesolowski LG; Wroblewski K; Gaynor AM
    J Clin Virol; 2018 Jul; 104():89-91. PubMed ID: 29803089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
    Ohhashi Y; Pai A; Halait H; Ziermann R
    J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic evaluation of a new combined HIV p24 antigen and anti-HIV1/2/O screening assay.
    Polywka S; Feldner J; Duttmann H; Laufs R
    Clin Lab; 2001; 47(7-8):351-6. PubMed ID: 11499796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sensitivity of screening kits for anti-HIV antibodies. 1999 update. Retrovirus Working Group of the French Society for Blood Transfusion].
    Couroucé AM
    Transfus Clin Biol; 1999 Dec; 6(6):381-94. PubMed ID: 10666796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion.
    Laforgerie E; Boucher B; Ly TD; Maisoneuve L; Izopet J; Delaugerre C; Simon F
    J Virol Methods; 2010 Apr; 165(1):105-7. PubMed ID: 20043952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The capacities of current test systems to verify early HIV infection].
    Baranova EN; Sharipova IN; Denisova NM; Susekina ME; Puzyrev VF; Sarkisian KA; Vorob'eva MS; Burkov AN; Ulanova TI
    Vopr Virusol; 2009; 54(5):37-40. PubMed ID: 19882902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low rates of p24 antigen detection using a fourth-generation point of care HIV test.
    Fox J; Dunn H; O'Shea S
    Sex Transm Infect; 2011 Mar; 87(2):178-9. PubMed ID: 21084439
    [No Abstract]   [Full Text] [Related]  

  • 53. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A novel enzyme immunoassay system for the detection of HIV-1 p24 antigen with a sensitivity of 0.5 pg/ml].
    Sharipova IN; Levina MA; Baranova EN; Obriadina AP; Burkov AN; Ulanova TI
    Klin Lab Diagn; 2008 Oct; (10):41-2. PubMed ID: 19069445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of human immunodeficiency virus type 1 subtype on HIV antibody detection in Burkina Faso.
    Gautier-Charpentier L; Ouedraogo-Traoré R; Simonon A; Meda N; Kpozehouen A; Dahourou H; Soudré R; Van de Perre P; Barin F
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):194-5. PubMed ID: 11588515
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of a new vesion of the human immunodeficiency virus antigen and antibody combination assay with improved sensitivity in HIV-1 p24 antigen detection].
    Sano T; Kondo M; Yoshimura Y; Tachikawa N; Sagara H; Itoda I; Yamanaka K; Sudo K; Kato S; Imai M
    Kansenshogaku Zasshi; 2013 Jul; 87(4):415-23. PubMed ID: 23984590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies.
    Alonso R; López Roa P; Suárez M; Bouza E
    J Clin Microbiol; 2014 May; 52(5):1467-70. PubMed ID: 24574285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay.
    Mühlbacher A; Schennach H; van Helden J; Hebell T; Pantaleo G; Bürgisser P; Cellerai C; Permpikul P; Rodriguez MI; Eiras A; Alborino F; Cunningham P; Axelsson M; Andersson S; Wetlitzky O; Kaiser C; Möller P; de Sousa G
    Med Microbiol Immunol; 2013 Feb; 202(1):77-86. PubMed ID: 22706797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The risk of a second diagnostic window with 4th generation HIV assays: Two cases.
    Niederhauser C; Ströhle A; Stolz M; Müller F; Tinguely C
    J Clin Virol; 2009 Aug; 45(4):367-9. PubMed ID: 19546027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV global surveillance: foundation for retroviral discovery and assay development.
    Brennan CA; Bodelle P; Coffey R; Harris B; Holzmayer V; Luk KC; Swanson P; Yamaguchi J; Vallari A; Devare SG; Schochetman G; Hackett J
    J Med Virol; 2006; 78 Suppl 1():S24-9. PubMed ID: 16622874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.